Stay updated with our latest news and announcements. Check back regularly for updates on our projects, events, and more!
Ozempic Impurities Explained: Ensuring Purity and Safety in Semaglutide-Based Therapies Semaglutide has emerged as a groundbreaking therapy for managing type 2 diabetes, marketed under brand names like... Read more AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025) We are pleased to announce that AMSbiopharma will be an official sponsor of the XIX Iberian Peptides Meeting... Read more Peptide Drugs: Discovery and Development Explained What Are Peptide Drugs and How Are They Used in Therapeutics? Peptide drugs, also known as therapeutic peptides,... Read more Application of Hydrophilic Interaction Chromatography (HILIC) in pharmaceutical analysis Analyzing polar compounds via high-performance liquid chromatography (HPLC) has long posed a challenge due to their limited retention... Read more How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,... Read more AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025) We are pleased to announce that AMSbiopharma will be an official sponsor of the XIX Iberian Peptides Meeting... Read more Peptide Drugs: Discovery and Development Explained What Are Peptide Drugs and How Are They Used in Therapeutics? Peptide drugs, also known as therapeutic peptides,... Read more Application of Hydrophilic Interaction Chromatography (HILIC) in pharmaceutical analysis Analyzing polar compounds via high-performance liquid chromatography (HPLC) has long posed a challenge due to their limited retention... Read more How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,... Read more AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
Peptide Drugs: Discovery and Development Explained What Are Peptide Drugs and How Are They Used in Therapeutics? Peptide drugs, also known as therapeutic peptides,... Read more Application of Hydrophilic Interaction Chromatography (HILIC) in pharmaceutical analysis Analyzing polar compounds via high-performance liquid chromatography (HPLC) has long posed a challenge due to their limited retention... Read more How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,... Read more AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
Application of Hydrophilic Interaction Chromatography (HILIC) in pharmaceutical analysis Analyzing polar compounds via high-performance liquid chromatography (HPLC) has long posed a challenge due to their limited retention... Read more How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,... Read more AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,... Read more AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the... Read more New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
New update for the ICH Q2 (R2) guidance on Analytical Process Validation As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2... Read more AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more
AMSbiopharma and LEF announce strategic partnership to expand service offering AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal... Read more